BKDT Fundamental Analysis - BROOKDALE SENIOR LIVING - BKD 7 11/15/25

Fundamental Rating

We assign a fundamental rating of 2 out of 10 to BKDT. BKDT was compared to 101 industry peers in the Health Care Providers & Services industry. Both the profitability and financial health of BKDT have multiple concerns. BKDT is valued expensive and it does not seem to be growing.

Quickly go to:

1. Profitability

1.1 Basic Checks

In the past year BKDT has reported negative net income.

In the past year BKDT had a positive cash flow from operations.

In the past 5 years BKDT reported 4 times negative net income.

BKDT had a positive operating cash flow in 4 of the past 5 years.

1.2 Ratios

BKDT's Return On Assets of -3.19% is in line compared to the rest of the industry. BKDT outperforms 42.73% of its industry peers.

BKDT's Return On Equity of -95.04% is on the low side compared to the rest of the industry. BKDT is outperformed by 76.36% of its industry peers.

BKDT has a Return On Invested Capital (0.76%) which is in line with its industry peers.

		Industry Rank	Sector Rank
ROA	-3.19%
ROE	-95.04%
ROIC	0.76%

ROA(3y)-3.53%

ROA(5y)-2.19%

ROE(3y)-60.92%

ROE(5y)-37.35%

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

BKDT has a Operating Margin of 1.76%. This is comparable to the rest of the industry: BKDT outperforms 47.27% of its industry peers.

In the last couple of years the Operating Margin of BKDT has grown nicely.

Looking at the Gross Margin, with a value of 25.57%, BKDT is in line with its industry, outperforming 50.91% of the companies in the same industry.

In the last couple of years the Gross Margin of BKDT has grown nicely.

		Industry Rank	Sector Rank
OM	1.76%
PM (TTM)	N/A
GM	25.57%

OM growth 3YN/A

OM growth 5Y54.21%

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y12.08%

GM growth 5Y3.43%

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so BKDT is destroying value.

The number of shares outstanding for BKDT has been increased compared to 1 year ago.

BKDT has more shares outstanding than it did 5 years ago.

The debt/assets ratio for BKDT has been reduced compared to a year ago.

2.2 Solvency

BKDT has an Altman-Z score of 1.14. This is a bad value and indicates that BKDT is not financially healthy and even has some risk of bankruptcy.

Looking at the Altman-Z score, with a value of 1.14, BKDT is doing worse than 63.64% of the companies in the same industry.

A Debt/Equity ratio of 20.19 is on the high side and indicates that BKDT has dependencies on debt financing.

The Debt to Equity ratio of BKDT (20.19) is worse than 84.55% of its industry peers.

		Industry Rank	Sector Rank
Debt/Equity	20.19
Debt/FCF	N/A
Altman-Z	1.14

ROIC/WACC0.09

WACC8.64%

2.3 Liquidity

BKDT has a Current Ratio of 0.88. This is a bad value and indicates that BKDT is not financially healthy enough and could expect problems in meeting its short term obligations.

BKDT has a Current ratio of 0.88. This is in the lower half of the industry: BKDT underperforms 78.18% of its industry peers.

A Quick Ratio of 0.88 indicates that BKDT may have some problems paying its short term obligations.

BKDT has a Quick ratio of 0.88. This is in the lower half of the industry: BKDT underperforms 70.91% of its industry peers.

		Industry Rank	Sector Rank
Current Ratio	0.88
Quick Ratio	0.88

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

The earnings per share for BKDT have decreased by -5.95% in the last year.

Looking at the last year, BKDT shows a small growth in Revenue. The Revenue has grown by 3.63% in the last year.

Measured over the past years, BKDT shows a decrease in Revenue. The Revenue has been decreasing by -5.08% on average per year.

EPS 1Y (TTM)-5.95%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%7.5%

Revenue 1Y (TTM)3.63%

Revenue growth 3Y4.25%

Revenue growth 5Y-5.08%

Sales Q2Q%3.51%

3.2 Future

BKDT is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 18.13% yearly.

The Revenue is expected to grow by 2.10% on average over the next years.

EPS Next Y34.18%

EPS Next 2Y19.37%

EPS Next 3Y18.13%

EPS Next 5YN/A

Revenue Next Year2.75%

Revenue Next 2Y-0.46%

Revenue Next 3Y2.1%

Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for BKDT. In the last year negative earnings were reported.

Also next year BKDT is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A

4.2 Price Multiples

BKDT's Enterprise Value to EBITDA is on the same level as the industry average.

		Industry Rank	Sector Rank
P/FCF	N/A
EV/EBITDA	46.27

4.3 Compensation for Growth

A more expensive valuation may be justified as BKDT's earnings are expected to grow with 18.13% in the coming years.

PEG (NY)N/A

PEG (5Y)N/A

EPS Next 2Y19.37%

EPS Next 3Y18.13%

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

BKDT has a Yearly Dividend Yield of 4.51%, which is a nice return.

BKDT's Dividend Yield is rather good when compared to the industry average which is at 2.43. BKDT pays more dividend than 97.27% of the companies in the same industry.

Compared to an average S&P500 Dividend Yield of 2.41, BKDT pays a better dividend.

		Industry Rank	Sector Rank
Dividend Yield	4.51%

5.2 History

BKDT has been paying a dividend for less than 5 years, so it still needs to build a track record.

Dividend Growth(5Y)N/A

Div Incr Years0

Div Non Decr Years0

5.3 Sustainability

DPN/A

EPS Next 2Y19.37%

EPS Next 3Y18.13%

More info and screens

Find the best dividend stocks

Show peers with best dividend

BROOKDALE SENIOR LIVING - BKD 7 11/15/25

NYSE:BKDT (3/27/2025, 8:04:01 PM)

77.6

-2.09 (-2.62%)

Chartmill FA Rating

GICS SectorHealth Care

GICS IndustryGroupHealth Care Equipment & Services

GICS IndustryHealth Care Providers & Services

Earnings (Last)02-18 2025-02-18/amc

Earnings (Next)05-05 2025-05-05

Inst Owners106.89%

Inst Owner ChangeN/A

Ins Owners3.68%

Ins Owner ChangeN/A

Market Cap15.53B

Analysts73.33

Price Target105.12 (35.46%)

Short Float %N/A

Short RatioN/A

Dividend

		Industry Rank	Sector Rank
Dividend Yield	4.51%

Yearly DividendN/A

Dividend Growth(5Y)N/A

DPN/A

Div Incr Years0

Div Non Decr Years0

Ex-Date02-14 2025-02-14 (0.875)

Surprises & Revisions

EPS beat(2)0

Avg EPS beat(2)-50.06%

Min EPS beat(2)-74.45%

Max EPS beat(2)-25.67%

EPS beat(4)1

Avg EPS beat(4)-21.47%

Min EPS beat(4)-74.45%

Max EPS beat(4)26.45%

EPS beat(8)3

Avg EPS beat(8)-5.89%

EPS beat(12)4

Avg EPS beat(12)-2.98%

EPS beat(16)7

Avg EPS beat(16)16.88%

Revenue beat(2)0

Avg Revenue beat(2)-1.05%

Min Revenue beat(2)-1.1%

Max Revenue beat(2)-1%

Revenue beat(4)0

Avg Revenue beat(4)-1.09%

Min Revenue beat(4)-1.2%

Max Revenue beat(4)-1%

Revenue beat(8)0

Avg Revenue beat(8)-0.88%

Revenue beat(12)0

Avg Revenue beat(12)-0.72%

Revenue beat(16)0

Avg Revenue beat(16)-1.27%

PT rev (1m)0%

PT rev (3m)0%

EPS NQ rev (1m)10.25%

EPS NQ rev (3m)22.22%

EPS NY rev (1m)8.42%

EPS NY rev (3m)8.42%

Revenue NQ rev (1m)0.22%

Revenue NQ rev (3m)0.39%

Revenue NY rev (1m)-0.06%

Revenue NY rev (3m)-1.4%

Valuation

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A
P/S	4.97
P/FCF	N/A
P/OCF	93.48
P/B	73.11
P/tB	83.9
EV/EBITDA	46.27

EPS(TTM)-0.89

EYN/A

EPS(NY)-0.59

Fwd EYN/A

FCF(TTM)-0.72

FCFYN/A

OCF(TTM)0.83

OCFY1.07%

SpS15.61

BVpS1.06

TBVpS0.92

PEG (NY)N/A

PEG (5Y)N/A

Profitability

		Industry Rank	Sector Rank
ROA	-3.19%
ROE	-95.04%
ROCE	0.96%
ROIC	0.76%
ROICexc	0.8%
ROICexgc	0.81%
OM	1.76%
PM (TTM)	N/A
GM	25.57%
FCFM	N/A

ROA(3y)-3.53%

ROA(5y)-2.19%

ROE(3y)-60.92%

ROE(5y)-37.35%

ROIC(3y)N/A

ROIC(5y)N/A

ROICexc(3y)N/A

ROICexc(5y)N/A

ROICexgc(3y)N/A

ROICexgc(5y)N/A

ROCE(3y)N/A

ROCE(5y)N/A

ROICexcg growth 3YN/A

ROICexcg growth 5Y47.69%

ROICexc growth 3YN/A

ROICexc growth 5Y48.52%

OM growth 3YN/A

OM growth 5Y54.21%

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y12.08%

GM growth 5Y3.43%

F-Score6

Asset Turnover0.49

Health

		Industry Rank	Sector Rank
Debt/Equity	20.19
Debt/FCF	N/A
Debt/EBITDA	10.15
Cap/Depr	84.26%
Cap/Sales	9.91%
Interest Coverage	0.23
Cash Conversion	39.32%
Profit Quality	N/A
Current Ratio	0.88
Quick Ratio	0.88
Altman-Z	1.14

F-Score6

WACC8.64%

ROIC/WACC0.09

Cap/Depr(3y)69.44%

Cap/Depr(5y)87.89%

Cap/Sales(3y)8.28%

Cap/Sales(5y)9.97%

Profit Quality(3y)N/A

Profit Quality(5y)N/A

High Growth Momentum

Growth

EPS 1Y (TTM)-5.95%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%7.5%

EPS Next Y34.18%

EPS Next 2Y19.37%

EPS Next 3Y18.13%

EPS Next 5YN/A

Revenue 1Y (TTM)3.63%

Revenue growth 3Y4.25%

Revenue growth 5Y-5.08%

Sales Q2Q%3.51%

Revenue Next Year2.75%

Revenue Next 2Y-0.46%

Revenue Next 3Y2.1%

Revenue Next 5YN/A

EBIT growth 1Y142.36%

EBIT growth 3YN/A

EBIT growth 5Y46.37%

EBIT Next Year517.25%

EBIT Next 3Y97.55%

EBIT Next 5YN/A

FCF growth 1Y-102.5%

FCF growth 3YN/A

FCF growth 5YN/A

OCF growth 1Y2%

OCF growth 3YN/A

OCF growth 5Y-5.14%

BROOKDALE SENIOR LIVING - BKD 7 11/15/25 (BKDT) Stock Fundamental Analysis

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

5.2 History

5.3 Sustainability

More info and screens